Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking an experienced clinical scientist to serve as Associate Director, Clinical Science in support of late-stage clinical programs. The Associate Director will independently lead defined clinical science workstreams and support execution of the registrational clinical development strategy.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines